Coffee With Polio Experts: Dr Ananda Bandyopadhyay

Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance

In this two-part video series, we chat with Dr Ananda Bandyopadhyay, Deputy Director of Polio Technology, Research & Analytics, BMGF, about the new tool in GPEI’s kit to combat cVDPV2: novel oral polio vaccine type 2 (nOPV2).

 


Related News

   26/01/2024
Health leaders call for focused efforts in endemic and most consequential geographies
   09/01/2024
WHO grants prequalification to innovative polio vaccine, nOPV2, as nearly 1 billion doses are administered
   18/12/2023
As the year draws to a close, efforts intensify against the virus in 2024
   20/11/2023
20 November 2023
   08/11/2023
Making the arduous journeys that underpin Yemen’s effort to end its poliovirus outbreak